GSA Capital Partners’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-12,433
Closed -$326K 2031
2017
Q2
$326K Buy
12,433
+3,349
+37% +$82.3K 0.02% 1227
2017
Q1
$213K Buy
+9,084
New +$224K 0.01% 1543
2016
Q1
Sell
-11,144
Closed -$390K 2070
2015
Q4
$390K Buy
+11,144
New +$349K 0.02% 1315
2015
Q3
Sell
-26,883
Closed -$895K 2192
2015
Q2
$895K Buy
26,883
+15,700
+140% +$482K 0.03% 994
2015
Q1
$315K Sell
11,183
-41,717
-79% -$1.04M 0.01% 1689
2014
Q4
$1.1M Sell
52,900
-10,467
-17% -$248K 0.08% 414
2014
Q3
$1.55M Buy
63,367
+17,284
+38% +$458K 0.08% 282
2014
Q2
$1.32M Buy
46,083
+21,500
+87% +$598K 0.06% 493
2014
Q1
$688K Buy
24,583
+11,400
+86% +$280K 0.05% 560
2013
Q4
$283K Sell
13,183
-11,200
-46% -$204K 0.02% 1248
2013
Q3
$324K Buy
24,383
+3,800
+18% +$51.2K 0.03% 1087
2013
Q2
$285K Buy
+20,583
New +$292K 0.03% 898

Other funds holding PMC

GSA Capital Partners's PMC Position: Q3 2017 in Review

GSA Capital Partners sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 12,433 shares — an estimated $326K sold.

GSA Capital Partners first reported a position in PMC in Q2 2013 and held it in 12 quarters. The position peaked at $1.55M in Q3 2014. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

  • GSA Capital Partners reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
  • GSA Capital Partners sold 12,433 PharMerica Corporation shares in Q3 2017, an estimated $326K.
  • GSA Capital Partners first reported a position in PharMerica Corporation in Q2 2013 and held it in 12 quarters.
  • GSA Capital Partners's PharMerica Corporation position peaked at $1.55M in Q3 2014.
  • 150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on GSA Capital Partners's 13F filing for Q3 2017, filed 20 Nov 2017.